***Background.*** Methicillin-resistant *Staphylococcus aureus* (MRSA) is highly prevalent in hospitals, and recently had emerged in community. Recent published data have shown an inconsistent association between methicillin-resistance and mortality in patients with *S. aureus* bacteremia (SAB). To understand the changing epidemiology of MRSA and the impact of methicillin-resistance on outcomes in adults with *S. aureus*bacteremia (SAB) and endocarditis, we performed a meta-analysis for database published after 2,000.

***Methods.*** We searched studies with SAB or endocarditis using electronic databases such as Ovid-Medline, EMBASE-Medline, and Cochrane Library, as well as five local databases for published studies during the period of January 2000 to September 2011. Two reviewers independently selected cohort studies, which compared in-hospital mortality or SAB-related mortality in adults with MRSA infection to those with methicillin-susceptible *S. aureus* (MSSA).

***Results.*** A total of 2,841 studies have been searched and of them, sixty-two with 17,563 adults were finally selected as eligible. A significant increase in overall mortality associated with MRSA, compared to that with MSSA, was evident with odds ratio (OR) of 1.95 (95% CI, 1.72-2.20, *I*^2^ = 43%; *P* \< 0.01). In sixteen studies which reported SAB-related mortality, OR was 2.04 (95% CI, 1 63-2.55). Methicillin-resistance in 13 endocarditis studies increased the risk for mortality, with OR of 2.49 (95% CI, 1.41-4.42). The average length of stay in MRSA group was 10 days longer than that in MSSA (95% CI, 3.36-16.70) Of six that have reported medical costs, two studies were integrated in the analysis resulting in estimated medical costs to be \$9,954.58 (95% CI, 8,951.99-10,957.17).

***Conclusion.*** Methicillin-resistance is still associated with increased mortality, hospital stay and medical cost, compared with susceptible one in SAB for published studies since the year of 2000.
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